JPWO2021111124A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021111124A5
JPWO2021111124A5 JP2022532865A JP2022532865A JPWO2021111124A5 JP WO2021111124 A5 JPWO2021111124 A5 JP WO2021111124A5 JP 2022532865 A JP2022532865 A JP 2022532865A JP 2022532865 A JP2022532865 A JP 2022532865A JP WO2021111124 A5 JPWO2021111124 A5 JP WO2021111124A5
Authority
JP
Japan
Prior art keywords
cirrhosis
colitis
lupus
dermatitis
suitably
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022532865A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023506147A (ja
JP7765088B2 (ja
JP2023506147A5 (https=
Publication date
Priority claimed from GBGB1917603.1A external-priority patent/GB201917603D0/en
Priority claimed from GBGB2015692.3A external-priority patent/GB202015692D0/en
Priority claimed from GBGB2015820.0A external-priority patent/GB202015820D0/en
Priority claimed from PCT/GB2020/053081 external-priority patent/WO2021111124A1/en
Application filed filed Critical
Publication of JP2023506147A publication Critical patent/JP2023506147A/ja
Publication of JPWO2021111124A5 publication Critical patent/JPWO2021111124A5/ja
Publication of JP2023506147A5 publication Critical patent/JP2023506147A5/ja
Priority to JP2025175449A priority Critical patent/JP2026027269A/ja
Publication of JP7765088B2 publication Critical patent/JP7765088B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022532865A 2019-12-02 2020-12-01 Mettl3阻害剤としてのポリヘテロ環式化合物 Active JP7765088B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025175449A JP2026027269A (ja) 2019-12-02 2025-10-17 Mettl3阻害剤としてのポリヘテロ環式化合物

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1917603.1A GB201917603D0 (en) 2019-12-02 2019-12-02 Inhibitory compounds
GB1917603.1 2019-12-02
GBGB2015692.3A GB202015692D0 (en) 2020-10-02 2020-10-02 Inhibitory compounds
GB2015692.3 2020-10-02
GB2015820.0 2020-10-06
GBGB2015820.0A GB202015820D0 (en) 2020-10-06 2020-10-06 Inhibitory compounds
PCT/GB2020/053081 WO2021111124A1 (en) 2019-12-02 2020-12-01 Polyheterocyclic compounds as mettl3 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025175449A Division JP2026027269A (ja) 2019-12-02 2025-10-17 Mettl3阻害剤としてのポリヘテロ環式化合物

Publications (4)

Publication Number Publication Date
JP2023506147A JP2023506147A (ja) 2023-02-15
JP2023506147A5 JP2023506147A5 (https=) 2023-12-07
JPWO2021111124A5 true JPWO2021111124A5 (https=) 2023-12-07
JP7765088B2 JP7765088B2 (ja) 2025-11-06

Family

ID=73854829

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022532865A Active JP7765088B2 (ja) 2019-12-02 2020-12-01 Mettl3阻害剤としてのポリヘテロ環式化合物
JP2025175449A Pending JP2026027269A (ja) 2019-12-02 2025-10-17 Mettl3阻害剤としてのポリヘテロ環式化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025175449A Pending JP2026027269A (ja) 2019-12-02 2025-10-17 Mettl3阻害剤としてのポリヘテロ環式化合物

Country Status (11)

Country Link
US (3) US12195458B2 (https=)
EP (1) EP4069694A1 (https=)
JP (2) JP7765088B2 (https=)
KR (1) KR20220113431A (https=)
CN (1) CN115151540A (https=)
AU (1) AU2020394867A1 (https=)
BR (1) BR112022010561A2 (https=)
CA (1) CA3162166A1 (https=)
IL (1) IL293340A (https=)
MX (1) MX2022006700A (https=)
WO (1) WO2021111124A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113905787A (zh) * 2019-04-05 2022-01-07 斯托姆治疗有限公司 Mettl3抑制化合物
IL293340A (en) 2019-12-02 2022-07-01 Storm Therapeutics Ltd Polyheterocyclic compounds as mettl3 inhibitors
US20230391770A1 (en) * 2020-10-06 2023-12-07 Storm Therapeutics Limited Mettl3 inhibitory compounds
GB202107905D0 (en) * 2021-06-02 2021-07-14 Storm Therapeutics Ltd Processes for the preparation of inhibitory compounds
GB202107907D0 (en) * 2021-06-02 2021-07-14 Storm Therapeutics Ltd Combination therapies
CN115894447B (zh) * 2021-09-22 2024-10-01 成都先导药物开发股份有限公司 Mettl3抑制剂及其用途
CN116514805A (zh) * 2021-12-10 2023-08-01 成都先导药物开发股份有限公司 Mettl3抑制剂化合物
WO2023129933A2 (en) * 2021-12-29 2023-07-06 858 Therapeutics, Inc. 6,6-fused heterocyclic compounds as mettl3 inhibitors
US20250145627A1 (en) 2022-02-11 2025-05-08 Xizang Haisco Pharmaceutical Co., Ltd. METTL3 Inhibitor and Composition, and Application of Same in Medicine
WO2023235756A1 (en) * 2022-05-31 2023-12-07 The Trustees Of The University Of Pennsylvania Compounds for the treatment of hiv
JP2025530847A (ja) * 2022-09-16 2025-09-17 北京華益健康薬物研究中心 Mettl3阻害剤化合物、その医薬組成物及び用途
GB202218672D0 (en) 2022-12-12 2023-01-25 Storm Therapeutics Ltd Inhibitory compounds
WO2024153775A1 (en) 2023-01-20 2024-07-25 Epics Therapeutics Piperidine derivatives as mettl3 inhibitors
WO2024200835A1 (en) 2023-03-30 2024-10-03 Novalix Novel mettl3 inhibitors and use thereof in therapy
CN119899188A (zh) * 2023-10-26 2025-04-29 杭州邦顺制药有限公司 Mettl3抑制剂
GB202316595D0 (en) 2023-10-30 2023-12-13 Storm Therapeutics Ltd Inhibitory compounds
GB202316683D0 (en) 2023-10-31 2023-12-13 Storm Therapeutics Ltd Inhibitory compounds
WO2025242921A1 (en) 2024-05-23 2025-11-27 Storm Therapeutics Limited Processes for the preparation of inhibitory compounds
CN121735955A (zh) * 2024-09-25 2026-03-27 中国科学院上海药物研究所 稠合双环类化合物及其制备方法、组合物和应用

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753664A (en) * 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
FR2734814B1 (fr) 1995-05-31 1997-07-04 Adir Nouveaux composes alkoxy-aryles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
BR9707495A (pt) 1996-02-13 1999-07-27 Zeneca Ltd Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente
US6291455B1 (en) 1996-03-05 2001-09-18 Zeneca Limited 4-anilinoquinazoline derivatives
US5928323A (en) 1996-05-30 1999-07-27 Sun Microsystems, Inc. Apparatus and method for dynamically generating information with server-side software objects
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
EP0966461A1 (en) 1997-03-21 1999-12-29 Novartis AG Pyrazole derivatives as herbicides
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
FR2783519B1 (fr) 1998-09-23 2003-01-24 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
SK288365B6 (sk) 1999-02-10 2016-07-01 Astrazeneca Ab Medziprodukty pre chinazolínové deriváty ako inhibítory angiogenézy
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
UA73993C2 (uk) 2000-06-06 2005-10-17 Астразенека Аб Хіназолінові похідні для лікування пухлин та фармацевтична композиція
CN1255392C (zh) 2000-07-07 2006-05-10 安吉奥金尼药品有限公司 作为血管生成抑制剂的秋水仙醇衍生物
IL153484A0 (en) 2000-07-07 2003-07-06 Angiogene Pharm Ltd Colchinol derivatives as angiogenesis inhibitors
CN1492874A (zh) 2000-12-21 2004-04-28 大环内酯
IL157412A0 (en) 2001-02-16 2004-03-28 Aventis Pharmaceuticals Inc Av Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
US7169795B2 (en) 2003-09-30 2007-01-30 Bristol Myers Squibb Company Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
KR20070010151A (ko) 2004-03-30 2007-01-22 사파이어 세라퓨틱스, 인크. 성장 호르몬 분비촉진제를 이용하여 c-반응성 단백질을감소시키는 방법
TW200700387A (en) 2005-03-21 2007-01-01 Akzo Nobel Nv 1-benzylindole-2-carboxamide derivatives
WO2006138549A1 (en) 2005-06-17 2006-12-28 Wyeth Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists
CA2622639C (en) 2005-10-04 2012-01-03 Istituto Di Recerche Di Biologia Molecolare P. Angeletti S.P.A. Hiv integrase inhibitors
KR20080064173A (ko) 2005-10-21 2008-07-08 글락소 그룹 리미티드 항균제로서 유용한 페리 축합 트리시클릭 화합물
US8247556B2 (en) 2005-10-21 2012-08-21 Amgen Inc. Method for preparing 6-substituted-7-aza-indoles
CN102633783A (zh) * 2006-02-10 2012-08-15 转化技术制药公司 作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
CA2656825C (en) 2006-06-22 2013-12-10 Prana Biotechnology Limited Method of treatment and agents useful for same
WO2008016666A2 (en) 2006-08-02 2008-02-07 Cytokinetics, Incorporated Certain chemical entities, compositions, and methods
US8202524B2 (en) * 2006-08-31 2012-06-19 Sk Chemicals Co., Ltd. Method for producing microspheres loaded with drugs and microspheres loaded with drugs produced thereby
WO2008074068A1 (en) 2006-12-20 2008-06-26 Prana Biotechnology Limited Substituted quinoline derivatives as antiamyloidogeneic agents
KR20090097194A (ko) 2006-12-22 2009-09-15 아벡사 리미티드 바이사이클 피리미디논 및 그 용도
CN101636398A (zh) * 2007-02-05 2010-01-27 泽农医药公司 用于治疗钠通道介导的疾病或疾病状态的吡啶并嘧啶酮化合物
WO2008100448A2 (en) 2007-02-13 2008-08-21 Helsinn Therapeutics (U.S.), Inc. Method of treating cell proliferative disorders using growth hormone secretagogues
CN101801965B (zh) 2007-08-17 2014-07-30 株式会社Lg生命科学 作为细胞坏死抑制剂的吲哚化合物
KR20100124272A (ko) 2008-02-07 2010-11-26 아보트 러보러터리즈 양성 알로스테릭 조절제로서의 아미드 유도체 및 이의 사용방법
WO2009127678A1 (en) * 2008-04-17 2009-10-22 Glaxo Group Limited Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71
CN102089297A (zh) * 2008-06-06 2011-06-08 雅培制药有限公司 新的1,2,4-噁二唑化合物和其使用方法
JP5539978B2 (ja) 2008-07-02 2014-07-02 アベキサ・リミテッド チアゾピリミジノンおよびその使用
EP2291377B1 (en) 2008-07-02 2015-02-18 Avexa Limited Imidazopyrimidinones and uses thereof
CN102143962B (zh) 2008-07-02 2015-03-11 爱维艾珂瑟有限公司 具有抗病毒特性的化合物
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
UY32138A (es) * 2008-09-25 2010-04-30 Boehringer Ingelheim Int Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
WO2010074101A1 (ja) * 2008-12-25 2010-07-01 住友化学株式会社 アミノピリジン化合物及びその用途
WO2010114898A1 (en) 2009-03-31 2010-10-07 Arqule, Inc. Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
EP2435080A2 (en) * 2009-05-29 2012-04-04 Abbott Laboratories Pharmaceutical compositions for the treatment of pain
WO2011050245A1 (en) 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
CN102336751A (zh) 2010-07-16 2012-02-01 爱维艾珂瑟有限公司 新型抗病毒剂
WO2012129562A2 (en) 2011-03-24 2012-09-27 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
TW201245185A (en) 2011-04-01 2012-11-16 Lundbeck & Co As H New positive allosteric modulators of nicotinic acetylcholine receptor
EP2812004B1 (en) 2012-02-10 2018-06-27 PTC Therapeutics, Inc. Compounds for treating spinal muscular atrophy
WO2014063199A1 (en) * 2012-10-26 2014-05-01 Akaal Pharma Pty Ltd Organic compounds
EP2977464A4 (en) 2013-03-19 2016-10-19 Toppan Printing Co Ltd PROCEDURE FOR PREDICTING SENSITIVITY TO EGFR HEMMER
US10195202B2 (en) 2013-12-19 2019-02-05 Ptc Therapeutics, Inc. Methods for modulating the amount of RNA transcripts
BR112016029825B1 (pt) 2014-06-17 2020-10-27 Cisen Pharmaceutical Co., Ltd. composto
AU2015276699B2 (en) 2014-06-17 2019-10-10 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pyridino[1,2-a]pyrimidone analogue used as PI3K inhibitor
JP6546654B2 (ja) 2014-08-22 2019-07-17 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited 淋菌感染を治療するための三環式含窒素化合物
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US10668171B2 (en) 2015-05-30 2020-06-02 Ptc Therapeutics, Inc. Methods for modulating RNA splicing
WO2017070464A1 (en) * 2015-10-22 2017-04-27 Memorial Sloan-Kettering Cancer Center Cofactor analogs as methyltransferase inhibitors for treating cancer
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US10730903B2 (en) * 2016-09-19 2020-08-04 Memorial Sloan-Kettering Cancer Center Adenosine analogs as methyltransferase inhibitors for treating cancer
JP2019535789A (ja) 2016-11-28 2019-12-12 ピーティーシー セラピューティクス,インコーポレーテッド Rnaスプライシングを調節する方法
MX390512B (es) 2017-03-26 2025-03-20 Takeda Pharmaceuticals Co Carboxamidas heteroaromáticas sustituidas con piperidinilo y piperazinilo como moduladores de gpr6.
CN107349217B (zh) * 2017-07-21 2020-06-09 深圳大学 一种基于mettl3的小干扰rna及其药物和应用
EP3589745A1 (en) * 2018-04-11 2020-01-08 Chemestmed Ltd. A method of modulating the rna methylation
CN112585119A (zh) 2018-08-14 2021-03-30 Epizyme股份有限公司 经取代的吲哚及其使用方法
SG11202105325QA (en) 2018-11-30 2021-06-29 Epizyme Inc Methods of treating whsc1-overexpressing cancers by inhibiting setd2
CN113905787A (zh) * 2019-04-05 2022-01-07 斯托姆治疗有限公司 Mettl3抑制化合物
IL293340A (en) 2019-12-02 2022-07-01 Storm Therapeutics Ltd Polyheterocyclic compounds as mettl3 inhibitors

Similar Documents

Publication Publication Date Title
JPWO2021111124A5 (https=)
JP2018188483A5 (https=)
JP2015038149A5 (https=)
RU2012141951A (ru) Курс лечения с использованием агониста рецептора sip
JP2016163571A5 (https=)
JP2017528507A5 (https=)
JP2019516739A5 (https=)
JP2017506624A5 (https=)
JP2015510916A5 (https=)
JP2021073257A5 (https=)
JP2019520344A5 (https=)
MX2020012377A (es) Uso de tabletas de desintegracion orales de riluzol para el tratamiento de enfermedades.
JP2019513814A5 (https=)
JP2021504384A5 (https=)
MX2024007642A (es) Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades.
RU2019135261A (ru) Фармацевтическая композиция, содержащая ингибитор pde9
JP2019518022A5 (https=)
JP2021503483A5 (https=)
JP2020510045A5 (https=)
JP2016537432A5 (https=)
JP2019507786A5 (https=)
JP2016528171A5 (https=)
JP2020530447A5 (https=)
HRP20251043T1 (hr) Novi oralni farmaceutski pripravak i režim doziranja za terapiju progresivnih fibrozirajućih intersticijskih bolesti pluća
JP2021512086A5 (https=)